- Cinzia Colombo, researcher1,
- Rita Banzi, researcher2
- 1Laboratory of Medical Analysis on Shopper Involvement, Division of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
- 2Centre for Well being Regulatory Insurance policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan
- cinzia.colombo{at}marionegri.it
Angelis and colleagues debunk the argument that prime costs are wanted to maintain drug growth.1 Their evaluation refers to a big physique of proof exhibiting that the majority drug industries make investments extra in promoting, administrative actions—together with advertising and marketing—and share buybacks than analysis and growth. Moreover, a number of research discovered that new medication have little or no therapeutic added worth.
Drug costs instantly have an effect on folks with a illness, when it comes to …
